Relapse Rates in Patients with GPA or MPA on Rituximab (RTX) Maintenance Therapy: A Single-Center Experience Observational Study from Saudi Arabia
Fortune Journal of Rheumatology · 2026 · 8 (2)
DOI: 10.26502/fjr.26880054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Rheumatology, 2026. Verfasst von Abdulrahman Alhumaidi und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alhumaidi, A., Qushmaq, K., Almatouq, B., Alamer, A., Alosaimi, A., Abdulhameed, R., Almansour, A., Abodarhem, A., Draz, H., & Albalawi., F. (2026). Relapse Rates in Patients with GPA or MPA on Rituximab (RTX) Maintenance Therapy: A Single-Center Experience Observational Study from Saudi Arabia. Fortune Journal of Rheumatology, 8(2). https://doi.org/10.26502/fjr.26880054
Vancouver
Alhumaidi A, Qushmaq K, Almatouq B, Alamer A, Alosaimi A, Abdulhameed R, et al. Relapse Rates in Patients with GPA or MPA on Rituximab (RTX) Maintenance Therapy: A Single-Center Experience Observational Study from Saudi Arabia. Fortune Journal of Rheumatology. 2026;8(2). doi:10.26502/fjr.26880054
BibTeX
@article{Alhumaidi2026,
author = {Alhumaidi, Abdulrahman and Qushmaq, Khalid and Almatouq, Bassim and Alamer, Ahmad and Alosaimi, Abdullah and Abdulhameed, Reemaz and Almansour, Abdulwahab and Abodarhem, Albatool and Draz, Huda and Albalawi., Faisal},
title = {Relapse Rates in Patients with GPA or MPA on Rituximab (RTX) Maintenance Therapy: A Single-Center Experience Observational Study from Saudi Arabia},
journal = {Fortune Journal of Rheumatology},
year = {2026},
volume = {8},
number = {2},
doi = {10.26502/fjr.26880054}
}
EUVIMED